Related Experiment Videos
Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction
Toshio Saito1, Yuko Yamamoto, Tsuyoshi Matsumura
1Division of Neurology, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan. saitot@toneyama.hosp.go.jp
Brain & Development
|August 27, 2005
Summary
Activated coagulation is linked to cardiac dysfunction in Duchenne muscular dystrophy (DMD). Significantly elevated thrombin-antithrombin complex (TAT) and prothrombin fragment (F1+2) were found in DMD patients with severely depressed left ventricular ejection fraction (LVEF).
Area of Science:
- Cardiovascular Medicine
- Hematology
- Neuromuscular Disorders
Background:
- Duchenne muscular dystrophy (DMD) is a progressive genetic disorder primarily affecting skeletal muscles.
- Cardiac dysfunction is a common and serious complication in DMD patients.
- The relationship between coagulation abnormalities and cardiac dysfunction in DMD requires further investigation.
Purpose of the Study:
- To investigate basic abnormalities of coagulation and fibrinolysis in Duchenne muscular dystrophy patients with varying degrees of cardiac dysfunction.
- To determine if specific coagulation markers correlate with left ventricular ejection fraction (LVEF) in DMD patients.
Main Methods:
- Forty-seven DMD patients (aged 13-37 years) were enrolled and categorized into three groups based on LVEF determined by echocardiography: markedly depressed (<30%), slightly depressed (30-50%), and normal (>50%).
- Serum levels of total fibrin and fibrinogen degradation products (FDP) were measured.
- Plasma levels of fibrinogen, thrombin-antithrombin complex (TAT), prothrombin fragment (F1+2), and D-dimer were quantified.
Main Results:
- Significantly elevated levels of thrombin-antithrombin complex (TAT) and prothrombin fragment (F1+2) were observed in the markedly depressed LVEF group compared to the other groups.
- No significant differences in serum FDP, plasma fibrinogen, or D-dimer levels were found among the three LVEF groups.
- These findings suggest a specific activation of the coagulation system in DMD patients with severe cardiac impairment.
Conclusions:
- Activated coagulation, indicated by elevated TAT and F1+2, is associated with cardiac dysfunction in Duchenne muscular dystrophy patients.
- These specific markers may serve as indicators of heightened thrombotic risk or underlying procoagulant state in DMD with cardiac involvement.
- Further research is warranted to explore the clinical implications and potential therapeutic targets related to coagulation activation in DMD.